UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor

Journal of clinical oncology, 2013-06, Vol.31 (17), p.2128-2135

2013

Volltextzugriff (PDF)

A Phase II Trial of Selinexor (KPT‐330) for Metastatic Triple‐Negative Breast Cancer

The oncologist (Dayton, Ohio), 2019-07, Vol.24 (7), p.887-e416

2019

Volltextzugriff (PDF)

Randomized Trial Using Gonadotropin-Releasing Hormone Agonist Triptorelin for the Preservation of Ovarian Function During (Neo)Adjuvant Chemotherapy for Breast Cancer

Journal of clinical oncology, 2012-02, Vol.30 (5), p.533-538

2012

Volltextzugriff (PDF)

Mindfulness-Based Stress Reduction in Post-treatment Breast Cancer Patients: Immediate and Sustained Effects Across Multiple Symptom Clusters

Journal of pain and symptom management, 2017-01, Vol.53 (1), p.85-95

2017

Volltextzugriff (PDF)

Urinary symptoms in breast cancer

Cancer, 2012-02, Vol.118 (3), p.582-593

2012

Volltextzugriff (PDF)

Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of Immunity

Frontiers in oncology, 2022-06, Vol.12

2022

Volltextzugriff (PDF)

Nuclear excision repair-based personalized therapy for non-small cell lung cancer: From hypothesis to reality

The international journal of biochemistry & cell biology, 2007-01, Vol.39 (7-8), p.1318-1328

2007

Volltextzugriff (PDF)

Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity

Frontiers in oncology, 2022-09, Vol.12, p.1007616-1007616

2022

Volltextzugriff (PDF)

Developing a Comprehensive Cardio-Oncology Program at a Cancer Institute: The Moffitt Cancer Center Experience

Oncology Reviews, 2017-07, Vol.11 (2), p.340-340

2017

Volltextzugriff (PDF)

Hypertensive Cardiotoxicity in Cancer Treatment—Systematic Analysis of Adjunct, Conventional Chemotherapy, and Novel Therapies—Epidemiology, Incidence, and Pathophysiology

Journal of clinical medicine, 2020-10, Vol.9 (10), p.3346

2020

Volltextzugriff (PDF)

Malignant Pleural Mesothelioma: A Comprehensive Review

Cancer control, 2006-10, Vol.13 (4), p.255-263

2006

Volltextzugriff (PDF)

Urinary Symptoms in Breast Cancer: A Systematic Review

Cancer, 2012-02, Vol.118 (3), p.582-593

2012

Volltextzugriff (PDF)

An Exploratory Study to Determine Whether BRCA1 and BRCA2 Mutation Carriers Have Higher Risk of Cardiac Toxicity

Genes, 2017-02, Vol.8 (2), p.59-59

2017

Volltextzugriff (PDF)

Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey

Cardio-oncology (London, England), 2020-11, Vol.6 (1), p.1-28, Article 28

2020

Volltextzugriff (PDF)

Ribociclib (LEE011) and letrozole in estrogen receptor-positive (ER+), HER2-negative (HER2–) advanced breast cancer (aBC): Phase Ib safety, preliminary efficacy and molecular analysis

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.568-568

2016

Volltextzugriff (PDF)

Florida Inter-Specialty Collaborative Project to Improve Cardio-Oncology Awareness and Identify Existing Knowledge Gaps

JACC CardioOncology, 2020-09, Vol.2 (3), p.535-538

2020

Volltextzugriff (PDF)

Patient reported physical and mental health changes associated with a comprehensive cardiovascular risk reduction program for women with breast cancer receiving potentially cardiotoxic chemotherapy

Cardio-oncology (London, England), 2021-05, Vol.7 (1), p.22-8, Article 22

2021

Volltextzugriff (PDF)

Comparison of breast magnetic resonance imaging clinical tumor size with pathologic tumor size in patients status post-neoadjuvant chemotherapy

The American journal of surgery, 2013-10, Vol.206 (4), p.567-573

2013

Volltextzugriff (PDF)

Phase 2 trial of docetaxel and gefitinib in the first‐line treatment of patients with advanced nonsmall‐cell lung cancer (NSCLC) who are 70 years of age or older

Cancer, 2008-05, Vol.112 (9), p.2021-2029

2008

Volltextzugriff (PDF)

The Benefit of Cardio-Oncology Programs for Cancer Patients

Oncology (Williston Park, N.Y.), 2019-02, Vol.33 (2), p.76

Ismail-Khan, Roohi

2019

Volltextzugriff (PDF)

Characteristics of Geriatric Triple-Negative Breast Cancer Patients

Journal of the American College of Surgeons, 2020-10, Vol.231 (4), p.S263-S264

2020

Volltextzugriff (PDF)

Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)

Journal of the American College of Cardiology, 2019-12, Vol.74 (25), p.3099-3108

2019

Volltextzugriff (PDF)

Abstract P5-11-05: The cardo-oncology concerns of combining tamoxifen and ribociclib based on the TEEL trial

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-11-05

2020

Volltextzugriff (PDF)

A phase I study of indoximod in patients with advanced malignancies

Oncotarget, 2016-04, Vol.7 (16), p.22928-22938

2016

Volltextzugriff (PDF)

CLINICAL CHARACTERISTICS AND OUTCOMES IN CARDIO-ONCOLOGY PATIENTS WITH COVID-19: ANALYSIS FROM THE COVID-19 AND CANCER CONSORTIUM (CCC19) DATABASE

Journal of the American College of Cardiology, 2021-05, Vol.77 (18), p.3133-3133

2021

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(71)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(33)
Humans
(23)
Oncology
(22)
Female
(16)
Middle Aged
(12)
Breast Cancer
(10)
Aged
(9)
Chemotherapy
(8)
Adult
(7)
Breast Neoplasms - Pathology
(7)
Cardiac & Cardiovascular Systems
(7)
Cardiovascular System & Cardiology
(7)
Male
(7)
Cancer
(6)
Cardio-Oncology
(6)
Cardiology
(6)
Aged, 80 And Over
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Breast Neoplasms - Drug Therapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor

A Phase II Trial of Selinexor (KPT‐330) for Metastatic Triple‐Negative Breast Cancer

Randomized Trial Using Gonadotropin-Releasing Hormone Agonist Triptorelin for the Preservation of Ovarian Function During (Neo)Adjuvant Chemotherapy for Breast Cancer

Mindfulness-Based Stress Reduction in Post-treatment Breast Cancer Patients: Immediate and Sustained Effects Across Multiple Symptom Clusters

Urinary symptoms in breast cancer

Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of Immunity

Nuclear excision repair-based personalized therapy for non-small cell lung cancer: From hypothesis to reality

Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity

Developing a Comprehensive Cardio-Oncology Program at a Cancer Institute: The Moffitt Cancer Center Experience

Hypertensive Cardiotoxicity in Cancer Treatment—Systematic Analysis of Adjunct, Conventional Chemotherapy, and Novel Therapies—Epidemiology, Incidence, and Pathophysiology

Malignant Pleural Mesothelioma: A Comprehensive Review

Urinary Symptoms in Breast Cancer: A Systematic Review

An Exploratory Study to Determine Whether BRCA1 and BRCA2 Mutation Carriers Have Higher Risk of Cardiac Toxicity

Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey

Ribociclib (LEE011) and letrozole in estrogen receptor-positive (ER+), HER2-negative (HER2–) advanced breast cancer (aBC): Phase Ib safety, preliminary efficacy and molecular analysis

Florida Inter-Specialty Collaborative Project to Improve Cardio-Oncology Awareness and Identify Existing Knowledge Gaps

Patient reported physical and mental health changes associated with a comprehensive cardiovascular risk reduction program for women with breast cancer receiving potentially cardiotoxic chemotherapy

Comparison of breast magnetic resonance imaging clinical tumor size with pathologic tumor size in patients status post-neoadjuvant chemotherapy

Phase 2 trial of docetaxel and gefitinib in the first‐line treatment of patients with advanced nonsmall‐cell lung cancer (NSCLC) who are 70 years of age or older

The Benefit of Cardio-Oncology Programs for Cancer Patients

Characteristics of Geriatric Triple-Negative Breast Cancer Patients

Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)

Abstract P5-11-05: The cardo-oncology concerns of combining tamoxifen and ribociclib based on the TEEL trial

A phase I study of indoximod in patients with advanced malignancies

CLINICAL CHARACTERISTICS AND OUTCOMES IN CARDIO-ONCOLOGY PATIENTS WITH COVID-19: ANALYSIS FROM THE COVID-19 AND CANCER CONSORTIUM (CCC19) DATABASE

Suchergebnisse filtern